MIDAZOLAM

Water soluble benzodiazepine medicine. Reserved for specialist use only

Dosage Forms

Injection

2 mg/ml

Uses

  • Febrile convulsions
  • Status epilepticus
  • Conscious sedation for procedures
  • Sedative in combined anaesthesia
  • Premedication before surgery or operation
  • Sedation of patients receiving intensive care

Dose and Duration

Status epilepticus and febrile convulsions

Adult and child over 10 years: by mouth, 10 mg repeated once after 10 minutes if required

Child 5–10 years: 7.5 mg by mouth repeated once after 10 minutes if required

Child 1–5 years: 5 mg by mouth as above

Child 3 months–1 year: 2.5 mg by mouth as above

Child under 3 months: 0.3 mg/kg (max 2.5 mg) by mouth

Neonate and child up to 18 years: by IV injection, initially 0.15–0.2 mg/kg followed by continuous IV infusion of 0.06 mg/kg/hour (increased by 0.06 mg/kg/hour every 15 minutes until seizure controlled). max 0.3 mg/kg/hour

Conscious sedation for procedures

By slow IV injection over 2–3 minutes 5–10 minutes before procedure

Adult: initially 2–2.5 mg by slow IV injection at a rate of about 2 mg/minute 5–10 minutes before procedure, increased if necessary in steps of 1 mg up to a usual total dose 3.5–5 mg (max 7.5 mg )

Elderly or debilitated: initially 0.5–1 mg (max 3.5 mg)

Child 1 month–18 years: by mouth, initially 0.025–0.05 mg/kg titrated in small steps up to a total dose of 7.5 mg, 10 mg and 6 mg for child 12–18 years, 6–12 years and 1 month–6 years respectively

Sedative in combined anaesthesia

Adult: by IV injection, 0.03–0.1 mg/kg repeated as required or by continuous IV infusion, 0.03–0.1 mg/kg/hour

Use lower dose in elderly

Premedication

Adult: by deep IM injection, 0.07–0.1 mg/kg 20–60 minutes before induction or by IV injection,1–2 mg 5–30 minutes before procedure repeated as required

Elderly or debilitated: by deep IM injection, 0.025–0.05 mg/kg 20–60 minutes before induction or by IV injection, 0.5 mg repeated slowly as required

Child 1 month–18 years: by mouth, 0.5 mg/kg (max 20 mg) 15–30 minutes before induction

Induction (but rarely used)

Adult: by slow IV injection, 0.15–0.2 mg/kg (0.05–0.15 mg/kg in the elderly or debilitated) in divided doses (max 5 mg) at intervals of 2 minutes. Max total dose 0.6 mg/kg

Child 7–18 years: initially by slow IV injection over 2–5 minutes, 0.15 mg/kg (max 7.5 mg) given in steps of 0.05 mg/kg (max 2.5 mg) every 2–5 minutes as required to a maximum total dose of 0.5 mg/kg of 25 mg

Sedation of patients receiving intensive care

Adult and child over 12 years: by slow IV injection, 0.03–0.3 mg/kg given in steps of 1–2.5 mg every 2 minutes, then by continuous IV infusion, 0.03–0.2 mg/kg/hour

Child 6 months–12 years: 0.05–0.2 mg/kg by slow IV injection over at least 3 minutes followed by continuous IV infusion of 0.03–0.12 mg/kg/hour, adjusted according to response

Child 1–6 months: 0.06 mg/kg/hour by continuous IV infusion adjusted according to response

Neonate: 0.06 mg/kg/hour by continuous IV infusion adjusted according to response (reduce dose to 0.03 mg/kg/hour after 24 hours in a neonate below 32 weeks gestational age). Treat for 4 days

Preparation

  • Injection can be diluted in apple or blackcurrant juice or cola for oral administration
  • For IV injection, dilute with glucose 5% or sodium chloride 0.9%
  • Neonatal intensive care, dilute 15 mg/kg body-weight to a final volume of 50 ml with infusion fluid. An IV infusion rate of 0.1 ml/hour provides a dose of 0.03 mg/kg/hour

Contraindications

  • Marked neuromuscular respiratory weakness including unstable myasthenia gravis
  • Severe respiratory depression
  • Acute pulmonary insufficiency
  • Sleep apnoea syndrome
  • Hypersensitivity to benzodiazepines

Side Effects

  • Anaphylactic shock, angioedema
  • Confusion, euphoria, hallucination, agitation, amnesia
  • Involuntary movements, sedation, headache, convulsions in premature babies
  • Cardiac arrest, bradycardia
  • Hypotension, vasodilation, thrombosis
  • Respiratory depression, apnoea
  • Nausea, vomiting, constipation, dry mouth
  • Rash, urticaria, pruritus

Interactions

  • Clarithromycin, erythromycin, telithromycin: (increased plasma concentration of midazolam)
  • Fluconazole, itraconazole, posaconazole, voriconazole: (plasma concentration of midazolam increased)
  • Atazanavir, ritonavir: (possibly increased concentration of midazolam)

Patient Instructions

  • Do not drive until you are certain that the medicine does not impair your ability to drive or use machines

Pregnancy

  • Can be used

Breast-feeding

  • Can be used

⚠️ Caution

  • Only use in presence of age and size-appropriate resuscitation facilities
  • Midazolam solution for injection may be given by mouth
  • Use with caution in mild to moderate hepatic impairment and avoid use in severe impairment
  • Use midazolam with caution in cardiac disease, myasthenia gravis and in history of drug and alcohol abuse
  • Use with caution in neonates and children especially those with cardiovascular impairment. Risk of airways obstruction and hypoventilation in children < 6 months
  • Reduce dose in the elderly and debilitated
  • Use with caution in hypovolemia, vasoconstriction and hypothermia due to risk of severe hypotension. Reduce or eliminate initial dose
  • Avoid prolonged use and abrupt withdrawal thereafter
  • Only use in pregnancy if clearly necessary
  • Avoid breast-feeding for 24 hours after administration
  • Midazolam is subject to abuse. Controlled storage and use same as for narcotics is necessary